Suppr超能文献

谷胱甘肽S-转移酶O1 A140D和谷胱甘肽S-转移酶O2 N142D基因变异与乳腺癌风险的关联

Association of GSTO1 A140D and GSTO2 N142D Gene Variations with Breast Cancer Risk.

作者信息

Sharif Mohammad Reza, Sharif Alireza, Kheirkhah Davood, Taghavi Ardakan Mahsa, Soltani Nika

机构信息

Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran. Email:

出版信息

Asian Pac J Cancer Prev. 2017 Jun 25;18(6):1723-1727. doi: 10.22034/APJCP.2017.18.6.1723.

Abstract

Background: Polymorphisms in glutathione S-transferase (GST) genes may contribute to breast cancer risk. The aim of this study was to investigate any association of two common GSTO1 A140D and GSTO2 N142D gene polymorphisms with breast cancer risk in an Iranian population followed by a protein structure analysis. Materials and Methods: In the case-control study, 303 subjects comprising 153 women with breast cancer and 150 healthy controls were included. Genotypes of GSTO1 A140D and GSTO2 N142D polymorphisms were assessed by PCRRFLP. Bioinformatics tools were employed to evaluate the damaging effects of A140D and N142D on the structures of GSTO1 and GSTO2 proteins. Results: Our genetic association study revealed that the GSTO1 A140D polymorphism was associated with breast cancer in a dominant model (OR= 1.75, 95%CI= 1.07-2.86, p= 0.026). Also, the A allele was significantly associated with breast cancer risk (OR= 1.69, 95%CI= 1.09-2.60, p= 0.018). With regard to the N142D polymorphism, there were significant associations between the GG genotype (OR= 2.20, 95%CI= 1.14-4.27, p= 0.019) and the G allele (OR= 1.47, 95%CI= 1.06-2.05, p= 0.021) and risk of breast cancer. Structural analysis revealed that A140D and N142D polymorphisms cause changes in both primary and secondary structures of GSTO1 and GSTO2, respectively. Conclusion: Based on our results, GSTO1 A140D and GSTO2 N142D polymorphisms could be genetic risk factors for breast cancer, but further studies with larger sample sizes focusing on different ethnicities are needed to obtain more comprehensive results.

摘要

背景

谷胱甘肽S-转移酶(GST)基因多态性可能与乳腺癌风险有关。本研究的目的是调查伊朗人群中两种常见的GSTO1 A140D和GSTO2 N142D基因多态性与乳腺癌风险之间的关联,并进行蛋白质结构分析。

材料与方法

在病例对照研究中,纳入了303名受试者,其中包括153名乳腺癌女性和150名健康对照。通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)评估GSTO1 A140D和GSTO2 N142D多态性的基因型。采用生物信息学工具评估A140D和N142D对GSTO1和GSTO2蛋白结构的破坏作用。

结果

我们的基因关联研究表明,GSTO1 A140D多态性在显性模型中与乳腺癌相关(比值比[OR]=1.75,95%置信区间[CI]=1.07-2.86,p=0.026)。此外,A等位基因与乳腺癌风险显著相关(OR=1.69,95%CI=1.09-2.60,p=0.018)。关于N142D多态性,GG基因型(OR=2.20,95%CI=1.14-4.27,p=0.019)和G等位基因(OR=1.47,95%CI=1.06-2.05,p=0.021)与乳腺癌风险之间存在显著关联。结构分析表明,A140D和N142D多态性分别导致GSTO1和GSTO2的一级和二级结构发生变化。

结论

基于我们的结果,GSTO1 A140D和GSTO2 N142D多态性可能是乳腺癌的遗传危险因素,但需要进行更大样本量、针对不同种族的进一步研究以获得更全面的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b1/6373817/b81e79527f3d/APJCP-18-1723-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验